Investors
The Investor page website contains information about Opsens Inc. business for stockholders, potential investors, and financial analysts.
Press Releases
We welcome you to Opsens’ Investor Relations website and would like to thank you for your interest in our company.
Through this website you can find comprehensive and detailed information about our IR activities and the performance of Opsens. Our website is especially tailored for institutional investors, analysts and private shareholders as well as anyone interested in Opsens’ financial performance.
Press releases 2022
|
OpSens Announces Fourth Quarter and Fiscal Year 2022 Financial Results November 22, 2022 |
Read more |
|
OpSens to Host Fourth Quarter Fiscal Year 2022 Financial Results Conference Call and Year-End Update on November 22, 2022 November 16, 2022 |
Read more |
|
OpSens Announces Departure of CFO November 1, 2022 |
Read more |
|
OpSens Announces First SavvyWire Clinical Cases in Europe and Launch of SAFE-TAVI Study October 26, 2022 |
Read more |
|
OpSens Announces First SavvyWire Procedure in the U.S. by Dr. Philippe Genereux of Morristown Medical Center September 23, 2022 |
Read more |
|
OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures September 15, 2022 |
Read more |
|
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022 September 14, 2022 |
Read more |
|
OpSens Announces Third Quarter Fiscal 2022 Financial Results With Record Quarterly Revenues July 14, 2022 |
Read more |
|
OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III July 11, 2022 |
Read more |
|
OpSens to Host Third Quarter Fiscal Year 2022 Financial Results Conference Call on Thursday, July 14 July 7, 2022 |
Read more |
|
OpSens Announces Global SavvyWire™ First Commercial Use June 7, 2022 |
Read more |
|
OpSens SavvyWire™ First-in-Human Results Presented at Europcr in Paris and Simultaneously Published in EuroIntervention Journal May 19, 2022 |
Read more |
|
OpSens Announces Publication in JSCAI – Data Supporting the Correlation Between the OptoWire and a Novel TAVR Interface with Standard of Care, Before and After TAVR May 18, 2022 |
Read more |
|
OpSens Announces Health Canada Approval For Its New TAVR Guidewire April 26, 2022 |
Read more |
|
OpSens Announces Second Quarter Fiscal 2022 Financial Results April 13, 2022 |
Read more |
|
OpSens to Host Second Quarter FY 2022 Financial Results Conference Call on Wednesday April 13 April 6, 2022 |
Read more |
|
OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th to 17th March 14, 2022 |
Read more |
|
OpSens Appoints Brad Davis as New Chief Commercial Officer February 9, 2022 |
Read more |
|
OpSens Announces Abiomed 4-year Supply Agreement Extension to 2028 February 1, 2022 |
Read more |
|
OpSens Named to 2022 OTCQX Best 50 January 24, 2022 |
Read more |
|
OpSens Announces First Quarter Fiscal 2022 Financial Results January 13, 2022 |
Read more |
|
OpSens to Host First Quarter FY 2022 Financial Results Conference Call on Thursday, January 13, 2022 January 6, 2022 |
Read more |
Press releases 2021
|
OpSens Announces 510(K) Submission to U.S. FDA for New Guidewire for the TAVR Procedure December 13, 2021 |
Read more |
|
OpSens to Present at the Lytham Partners Winter 2021 Investor Conference Presentation at 11 AM (ET), Monday December 13, 2021 December 7, 2021 |
Read more |
|
OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results November 23, 2021 |
Read more |
|
OpSens Successfully Completes 20-Patient In-Human Clinical Study for TAVR Procedure November 23, 2021 |
Read more |
|
OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021 November 17, 2021 |
Read more |
|
OpSens Will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity MedTech & Diagnostics Forum November 10, 2021 |
Read more |
|
OpSens’ SavvyWire™ Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando November 8, 2021 |
Read more |
|
OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure October 13, 2021 |
Read more |
|
OpSens to Present at the Lytham Partners Fall 2021 Investor Conference – Tuesday, October 5, 2021, 9:30 AM September 29, 2021 |
Read more |
|
OpSens Receives Approval from Health Canada to Initiate First In-Man Study For its New Guidewire For the TAVR Procedure September 20, 2021 |
Read more |
|
OpSens Appoints Lori Chmura to its Board of Directors September 8, 2021 |
Read more |
|
OpSens Announces Third Quarter Fiscal 2021 Record Financial Results July 13, 2021 |
Read more |
|
OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13 July 7, 2021 |
Read more |
|
OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts June 16, 2021 |
Read more |
|
OpSens Will Participate and Present at Two Investment Conferences Lytham Partners and Raymond James June 9, 2021 |
Read more |
|
OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference May 13, 2021 |
Read more |
|
OpSens Integrates its OptoWire’s dPR and FFR Algorithms within Cathmedical Cardiovascular’s Picasso System in Spain April 21, 2021 |
Read more |
|
OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues April 14, 2021 |
Read more |
|
OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III April 7, 2021 |
Read more |
|
OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 – Conference call to be conducted at 11:00 am ET April 6, 2021 |
Read more |
|
OpSens to Present at Lytham Partners Spring 2021 Investor Conference – Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021 March 22, 2021 |
Read more |
|
OpSens: Closing of $28.75 M Bought Deal Public Offering – Including $3.75 M Over-Allotment Option Exercised in Full February 25, 2021 |
Read more |
|
OpSens Obtains CE Marking for the OptoWire III February 18, 2021 |
Read more |
|
OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER) February 8, 2021 |
Read more |
|
OpSens Announces $25 Million Bought Deal Offering February 5, 2021 |
Read more |
|
OpSens Announces First Quarter fiscal 2021 financial Results January 13, 2021 |
Read more |
|
OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021 January 6, 2021 |
Read more |
Press releases 2020
|
OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference November 24, 2020 |
Read more |
|
OpSens announces fourth quarter and fiscal year 2020 results November 19, 2020 |
Read more |
|
OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™ November 18, 2020 |
Read more |
|
OpSens to Present at the Virtual Fall Investor Summit On November 16 November 13, 2020 |
Read more |
|
OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020 November 12, 2020 |
Read more |
|
OpSens to Present at the Virtual Fall Investor Summit On November 16 November 10, 2020 |
Read more |
|
OpSens Awarded Contract by Major U.S. Group Purchasing Organization October 14, 2020 |
Read more |
|
OpSens to Present at Lytham Partners Virtual Investor Growth Conference September 30, 2020 |
Read more |
|
OpSens to Present at the LD 500 Virtual Conference August 26, 2020 |
Read more |
|
OpSens Announces Q3 Results 2020 July 15, 2020 |
Read more |
|
Opsens – 100,000 Cases Performed with the OptoWire May 20, 2020 |
Read more |
|
OpSens at C-Suite at the Open April 27, 2020 |
Read more |
|
OpSens – Message to the medical community, Covid-19 April 9, 2020 |
Read more |
|
OpSens Announces Q2 2020 Results April 9, 2020 |
Read more |
|
OPSENS PROVIDES OPERATIONAL UPDATE – Continues to supply essential cardiovascular solutions to patients around the world March 24, 2020 |
Read more |
|
Opsens receives FDA approval of OptoWire III – Improved handling and lower cost of production January 13, 2020 |
Read more |
|
OpSens Announces Q1 2020 Results January 13, 2020 |
Read more |
Press releases 2019
|
OPSENS RECEIVES dPR CLEARANCE FROM FDA December 19, 2019 |
Read more |
|
OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41% November 14, 2019 |
Read more |
|
OPSENS – FIRST CLINICAL USE OF OPTOWIRE III AFTER HEALTH CANADA APPROVAL November 7, 2019 |
Read more |
|
OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET November 5, 2019 |
Read more |
|
OPSENS SOLUTIONS – STRATEGIC ORDER FOR FIBER OPTIC SENSORS TO BE DEPLOYED IN NEW INDUSTRIAL DEWATERING PROCESS July 16, 2019 |
Read more |
|
OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49% July 11, 2019 |
Read more |
|
OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER June 17, 2019 |
Read more |
|
OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT June 11, 2019 |
Read more |
|
OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL May 22, 2019 |
Read more |
|
OPSENS SIGNS LANDMARK SUPPLIER AGREEMENT – EXPANDS OPTICAL SENSING TECHNOLOGY IMPACT WITHIN CARDIOLOGY SEGMENT April 30, 2019 |
Read more |
|
OPSENS – Q2 2019 REVENUES REACH $7.9 M, A 46% INCREASE April 11, 2019 |
Read more |
|
OPSENS APPOINTS ALAN MILINAZZO AS EXECUTIVE CHAIRMAN OF THE BOARD OF DIRECTORS March 4, 2019 |
Read more |
|
OPSENS ANNOUNCES CREDIT AGREEMENT WITH CIBC INNOVATION BANKING February 27, 2019 |
Read more |
|
OPSENS – Q1 2019 REVENUES REACH A RECORD HIGH OF $9.1 M, A 43% INCREASE January 14, 2019 |
Read more |
|
OPSENS’ dPR OBTAINS CE MARKING TO SELL IN EUROPE January 9, 2019 |
Read more |
Press releases 2018
|
OPSENS REPORTS Q4 and FY2018 RESULTS – RECORD ANNUAL REVENUE SURPASS $24 M AND RECORD QUARTERLY FFR REVENUES AT $4.1 M November 28, 2018 |
Read more |
|
OPSENS RECEIVES HEALTH CANADA APPROVAL FOR dPR INTENDED FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST November 27, 2018 |
Read more |
|
OPSENS – FIRST USE OF dPR FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST November 8, 2018 |
Read more |
|
OPSENS – 50,000 PATIENTS DIAGNOSED WITH THE OPTOWIRE November 1, 2018 |
Read more |
|
OPSENS TO HOST INVESTOR WEBINAR ON THURSDAY, OCTOBER 4 TO PROVIDE UPDATE ON RECENT DEVELOPMENTS October 3, 2018 |
Read more |
|
OPSENS – NEW PRODUCT FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST September 20, 2018 |
Read more |
|
OPSENS REPORTS Q3 2018 RESULTS – Quarterly Revenues Eclipse $6.4 M July 12, 2018 |
Read more |
|
OPSENS APPLAUDS JAPANESE GOVERNMENT NEW REGULATION SUPPORTING DIAGNOSIS, SUCH AS FFR, BEFORE TREATMENT OF CORONARY STENOSIS April 24, 2018 |
Read more |
|
OPSENS REPORTS Q2 2018 RESULTS – CONSOLIDATED PRODUCT SALES UP 44% April 12, 2018 |
Read more |
|
OPSENS’ TECHNOLOGY GRANTED FDA APPROVAL IN ABIOMED’S IMPELLA CARDIAC PUMP® April 3, 2018 |
Read more |
|
OPSENS ANNOUNCES ELECTION RESULTS FOR THE BOARD OF DIRECTORS AND THE RETIREMENT OF CLAUDE BELLEVILLE January 23, 2018 |
Read more |
|
OPSENS REPORTS Q1 2018 RESULTS – RECORD QUARTERLY REVENUES WITH GROWTH IN ALL GEOGRAPHIC REGIONS January 16, 2018 |
Read more |
Press releases 2017
|
OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE November 27, 2017 |
Read more |
|
OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 November 15, 2017 |
Read more |
|
OPSENS GETS TECHNOLOGICAL AWARD October 24, 2017 |
Read more |
|
OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL September 19, 2017 |
Read more |
|
Opsens – Q3 Results June 29, 2017 |
Read more |
|
ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER June 7, 2017 |
Read more |
|
OPSENS ANNOUNCES DEPARTURE OF CFO May 5, 2017 |
Read more |
|
OPSENS REPORTS Q2 2017 RESULTS – QUARTERLY CONSOLIDATED REVENUES UP 75% TO $4.8 MILLION April 19, 2017 |
Read more |
|
OPSENS ANNOUNCES GRADUATION TO TSX February 28, 2017 |
Read more |
|
OPSENS REPORTS Q1 2017 RESULTS – FOCUSED EXECUTION LEADS TO RECORD QUARTERLY REVENUES January 26, 2017 |
Read more |
Press releases 2016
|
OPSENS INC. COMPLETES A $14.95 MILLION EQUITY FINANCING BY WAY OF PROSPECTUS December 8, 2016 |
Read more |
|
OPSENS ANNOUNCES UPSIZE TO AND PROVIDES ADDITIONAL DETAILS REGARDING ITS PROPOSED EQUITY FINANCING November 23, 2016 |
Read more |
|
Opsens Announces Equity Financing November 23, 2016 |
Read more |
|
OPSENS REPORTS RESULTS FOR 2016 – RECORD TOTAL REVENUES DRIVEN BY TENFOLD INCREASE IN FFR SALES November 16, 2016 |
Read more |
|
OPSENS RECEIVES 510(K) CLEARANCE FOR THE OPTOMONITOR II PROVIDING EXTENDED INDICATION September 26, 2016 |
Read more |
|
OPSENS ANNOUNCES PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES IN THE ENERGY SECTOR September 22, 2016 |
Read more |
|
OPSENS APPOINTS PAT MACKIN TO ITS BOARD OF DIRECTORS September 7, 2016 |
Read more |
|
CIRCULATION JOURNAL HIGHLIGHTS OPTOWIRE PERFORMANCE August 31, 2016 |
Read more |
|
OPSENS Q3 RESULTS – SALES OF $2,125,000, UP 156% YEAR-OVER-YEAR July 5, 2016 |
Read more |
|
OPSENS: HEALTH CANADA APPROVAL FOR THE SALE OF OPTOWIRE II June 22, 2016 |
Read more |
|
OPSENS COMPLETES $5 MILLION PRIVATE PLACEMENT May 17, 2016 |
Read more |
|
OPSENS ANNOUNCES RESULTS FOR ITS SECOND QUARTER 2016 April 21, 2016 |
Read more |
|
OPSENS RECEIVES FDA 510(K) CLEARANCE FOR THE OPTOWIRE II March 16, 2016 |
Read more |
|
OPSENS NAMED TO THE 2016 TSX VENTURE TOP 50® March 10, 2016 |
Read more |
|
OPSENS HIRES GEORGE QUINOY AS VP/GM U.S. COMMERCIAL SALES & OPERATIONS January 25, 2016 |
Read more |
|
OPSENS REPORTS Q1 2016 RESULTS January 19, 2016 |
Read more |
Press releases 2015
|
OPSENS COMPLETES A $5 M FINANCING December 22, 2015 |
Read more |
|
OPSENS – DETAILS ON PROPOSED FINANCING December 3, 2015 |
Read more |
|
OPSENS ANNOUNCES EQUITY FINANCING December 3, 2015 |
Read more |
|
$1.2 M ORDERS FOR OPSENS’ FFR PRODUCTS November 30, 2015 |
Read more |
|
OPSENS GRANTED APPROVAL TO SELL OPTOWIRE II IN JAPAN November 26, 2015 |
Read more |
|
OPSENS REPORTS 2015 RESULTS November 24, 2015 |
Read more |
|
OPSENS APPROVED TO SELL OPTOWIRE II IN EUROPE November 12, 2015 |
Read more |
|
Opsens – First use of its FFR products in the U.S. November 12, 2015 |
Read more |
|
Opsens – 1,000th procedure with the OptoWire November 12, 2015 |
Read more |
|
OPSENS TO PRESENT LIVE VIA WEBCAST AT VIRTUALINVESTORCONFERENCES.COM ON OCTOBER 1, 2015 AT 9:15AM ET September 29, 2015 |
Read more |
|
OPSENS HIRES TONY GIBBONS AS VICE PRESIDENT, SALES AND MARKETING September 16, 2015 |
Read more |
|
OPSENS ANNOUNCES THE RESIGNATION OF A DIRECTOR September 16, 2015 |
Read more |
|
Opsens Announces a Reorganization of its Corporate Structure September 3, 2015 |
Read more |
|
OPSENS ANNOUNCES AN ENERGY SECTOR PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES August 28, 2015 |
Read more |
|
OPSENS RECEIVES HEALTH CANADA APPROVAL TO COMMERCIALIZE ITS FFR PRODUCTS July 21, 2015 |
Read more |
|
OPSENS – RESULTS FOR THIRD QUARTER 2015 July 2, 2015 |
Read more |
|
OPSENS MOVES FFR ACTIVITIES TO INCREASE MANUFACTURING CAPACITY June 17, 2015 |
Read more |
|
OPSENS GETS CLEARANCE TO SELL FFR PRODUCTS IN THE UNITED STATES June 15, 2015 |
Read more |
|
OPSENS ANNOUNCES FIRST USE OF ITS FFR PRODUCTS BY DR. NICO PIJLS May 20, 2015 |
Read more |
|
OPSENS – SECOND QUARTER 2015 RESULTS April 21, 2015 |
Read more |
|
OPSENS’ SHARES NOW TRADED ON THE OTCQX MARKETPLACE IN U.S. March 31, 2015 |
Read more |
|
Opsens appoints Denis Harrington to its Board of Directors January 20, 2015 |
Read more |
|
Opsens – results of first quarter 2015 January 19, 2015 |
Read more |
Press Releases 2013
| 2013-11-26 | Opsens reports fourth quarter results | Read more |
| 2013-11-13 | Opsens ranks on Deloitte’sTechnology Fast 50 program | Read more |
| 2013-07-04 | Opsens reports third quarter results | Read more |
| 2013-06-03 | Opsens On Profit 500 | Read more |
| 2013-04-23 | Opsens releases Q2 | Read more |
| 2013-04-19 | OPSENS PARTICIPATES IN GOLDMAN SACHS EMERGING HEALTHCARE SERIES | Read more |
| 2013-03-12 | OPSENS RECEIVES LARGEST-EVER ORDER FOR ITS OPP-W FIBER OPTIC PRESSURE AND TEMPERATURE SENSORS | Read more |
| 2013-02-20 | Opsens Successfully Deploys A Pressure and Temperature System on PTRC’S Aquistore Project, Saskatchewan, Canada | Read more |
| 2013-01-22 | Opsens reaches profitability in Q1 | Read more |
| 2013-01-07 | Changes at senior management level | Read more |
Press Releases 2012
| 2012-11-27 | Opsens announces highest revenue ever in FY2012 | Read more |
| 2012-11-19 | Opsens signs a distribution agreement for its FFR products in Asia in a US$ 5million transaction | Read more |
| 2012-07-04 | Q3 Results | Read more |
| 2012-04-24 | Q2 Results – 78% Revenue Increase | Read more |
| 2012-03-02 | OPSENS SETTLES FFR LAWSUIT | Read more |
| 2012-01-17 | Q1 results – 118% revenue increase | Read more |
Press Releases 2011
| 2011-11-15 | Opsens – Q4 Results | Read more |
| 2011-10-17 | Opsens – Canadian Patent for the EasyWire for FFR | Read more |
| 2011-10-12 | MULTI-WELL ORDER TO INSTRUMENT HIGH-TEMPERATURE RESERVOIRS WITH OPP-W SENSORS AND DTS | Read more |
| 2011-09-13 | Opsens receives ISO 13485 certification for FFR | Read more |
| 2011-09-06 | Opsens and Lios sign agreement | Read more |
| 2011-07-26 | OPSENS RECEIVES SECOND COMMERCIAL ORDER FOR ITS OPP-W FIBER OPTIC PRESSURE SENSORS – 21 WELLS FROM MAJOR ALBERTA OIL PRODUCER | Read more |
| 2011-07-05 | OPSENS REPORTS Q3 2011 RESULTS WITH BEST-EVER QUARTERLY REVENUE | Read more |
| 2011-06-07 | OPSENS WINS ORDER TO INSTRUMENT HIGH-TEMPERATURE WELLS FOR SAGD PRODUCER | Read more |
| 2011-04-19 | Opsens – Q2 | Read more |
| 2011-03-09 | OPSENS WILL STRONGLY DEFEND AGAINST ACIST LAWSUIT | Read more |
| 2011-02-23 | Opsens – EasyWire & OptoWire, preclinical trials | Read more |
| 2011-01-21 | Opsens reports Q1 results | Read more |
| 2011-01-12 | OPP-W and DTS combination order for multi-zone observation well from new client | Read more |
| 2011-01-10 | Opsens unveils second medical device for FFR market | Read more |
Press Releases 2010
| 2010-12-20 | Opsens unveils medical device for FFR market | Read more |
| 2010-12-07 | Orders for OPP-W sensors associated with DTS | Read more |
| 2010-11-18 | OPSENS ANNOUNCES 71% SALES GROWTH FOR 2010 | Read more |
| 2010-10-19 | New client orders OPP-W in Alberta | Read more |
| 2010-09-29 | Opsens selected to design and produce well integrity tool | Read more |
| 2010-09-01 | Opsens – New President for Opsens Solutions | Read more |
| 2010-08-31 | Opsens appoints three directors | Read more |
| 2010-08-17 | Opsens transfers transformers business to LumaSense | Read more |
| 2010-07-07 | Opsens reports Q3 2010 results with best-ever quarterly revenue | Read more |
| 2010-05-06 | Opsens gets additional orders for reservoir surveillance systems for CO2-EOR project | Read more |
| 2010-04-21 | Opsens reports second quarter results | Read more |
| 2010-04-06 | Opsens receives follow-on order from OPP-W customer | Read more |
| 2010-02-12 | Opsens announces closing of private placement | Read more |
| 2010-02-05 | Opsens named as part of 2010 TSX venture 50 | Read more |
| 2010-02-01 | Opsens announces private placement | Read more |
| 2010-01-27 | Abiomed announces partnership with Opsens to utilize sensor technology for Impella | Read more |
| 2010-01-20 | Opsens reports first quarter 2010 results | Read more |
Press Releases 2009
| 2009-11-23 | Opsens announces order from a large integrated oil company for casing-conveyed permanent observation well in co2-eor project | Read more |
| 2009-11-18 | Opsens reports FY 2009 results | Read more |
| 2009-10-15 | Opsens receives multi-well order for fiber optic pressure sensors from major Alberta oil producer. | Read more |
| 2009-07-08 | Opsens receives grant from NRC-IRAP to develop new medical device. | Read more |
| 2009-07-07 | Opsens reports 3Q results – Quarterly revenue exceed $1 million | Read more |
| 2009-06-25 | Opsens announces closing of $1.75 million private placement. | Read more |
| 2009-06-19 | OPSENS announces $2 million private placement | Read more |
| 2009-05-08 | OPP-W sensors withstand the test of time in extremely harsh down-hole oilfield environment. | Read more |
| 2009-04-22 | Opsens reports 2Q results, including a record backlog | Read more |
| 2009-03-03 | Opsens sells 60 PowerSens II systems to power company | Read more |
| 2009-02-27 | Opsens announces repeat order from a large integrated oil company for multi-well installation of fiber optic sensors | Read more |
| 2009-02-10 | Opsens launches new miniature pressure sensor for life sciences & medical devices | Read more |
| 2009-02-02 | Opsens launches new signal conditioner for power transformer sector | Read more |
| 2009-01-21 | Opsens announces results for first quarter of 2009 | Read more |
Press Releases 2008
| 2008-12-01 | Opsens announces order repeat from oil sands client | Read more |
| 2008-11-20 | Opsens receives sensor order from major canadian oil sands operator. | Read more |
| 2008-11-20 | Opsens announces fourth quarter and FY2008 results. | Read more |
| 2008-10-20 | Opsens inc. receives ISO 9001:2000 certification. | Read more |
| 2008-07-04 | Opsens inc. announces 376% sales growth for third quarter 2008 | Read more |
| 2008-04-23 | Opsens inc. announces 140% sales growth for second quarter 2008. | Read more |
| 2008-04-08 | Opsens inc. announces closing $3,8 million brokered private placement. | Read more |
| 2008-03-26 | Opsens inc. announces CAD$4,00 million brokered private placement. | Read more |
| 2008-01-22 | Opsens inc. announces 327 % sales growth for first quarter 2008. | Read more |
| 2008-01-09 | Opsens inc. announces two new orders in the Oil & Gas. | Read more |
Press Releases 2007
| 2007-12-12 | Opsens inc. concludes the acquisition of Inflo Solutions in Alberta to integrate its operations in Oil & Gas. | Read more |
| 2007-11-28 | Opsens inc. publishes its annuel results for the fiscal year ended August 31, 2007 and sees record level order backlog. | Read more |
| 2007-11-21 | Opsens inc. announces an order from a european medical customer. | Read more |
| 2007-11-05 | Opsens inc. announces $6,25 million private placement. | Read more |
| 2007-10-29 | Opsens inc. receives first order from japanese manufacturer for cardiovascular pressure measurement. | Read more |
| 2007-10-24 | Opsens inc. announces new orders from the EED market on three continents. | Read more |
| 2007-10-17 | Opsens inc. announces an order from BAE Systems. | Read more |
| 2007-10-16 | Opsens’ RadSens System accepted for RADHAZ Applications by the United Kingdom MoD DOSG. | Read more |
| 2007-08-21 | USPTO grants a patent on main Opsens technology. | Read more |
| 2007-08-13 | Opsens inc. completes with success the evaluation of its signal conditioner from an european medical customer. | Read more |
| 2007-07-04 | Opsens inc. announces its financial results for the quarter ended May 31, 2007. | Read more |
| 2007-05-15 | Opsens inc. completes an important milestone in its history with an order received from a major oil sands operator in Alberta for the supply and installation of its optical sensing systems. | Read more |
| 2007-04-25 | Opsens inc. announces the nomination to its advisory committee of Maurice B. Dusseault, well-known expert in heavy oil and oil sands production processes. | Read more |
| 2007-04-24 | Opsens inc. announces its financial results for the quarter ended February 28, 2007. | Read more |
| 2007-04-16 | Opsens inc. names Yves Plamondon as vice president sales & marketing. | Read more |
| 2007-03-22 | Opsens inc. announces an order from a high-potential client in the medical indus | Read moretry. |
| 2007-01-25 | Opsens inc. announces its financial results for the quarter ended November 30, 2006. | Read more |
Press Releases 2006
| 2006-12-05 | Opsens inc. closes a private placement with a premier US financial institution and a private investor for an amount of $1,100,000. | Read more |
| 2006-10-11 | Opsens Inc. closes a second private placement of $1,175,000 for a total aggregate private placement of $2,215,000 | Read more |
| 2006-10-03 | Opsens Inc. closes a qualifying transaction with DCB Capital Inc. and closes a private placement of $1,040,000 | Read more |
* Links to third party sites are for informational purposes only. Opsens Inc. have not prepared, reviewed or updated any content on third party sites and assume no responsibility for the information posted on them.